Effect of Droplet-Wake Phenomena on Mixing-Sensitive Pharmaceutical Reactions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Effect of Droplet-Wake Phenomena on Mixing-Sensitive Pharmaceutical Reactions


Pharmaceutical Technology


The continuous phase was charged to the column and allowed to settle to remove all visible air droplets. The iodine solution was injected subsurface using a 20-gauge PTFE needle. Droplets were released at least 4 s apart, thus guaranteeing that a local steady-state had been reached. The iodine charge times for the reported experiments varied between 0.25 and 3.0 h. For analysis purposes, only a 300-mL sample was collected from the middle section of the column with a set of valves. All of the remaining continuous phase was drained to waste, and the sample was analyzed using HPLC.


Table III: Experimental properties.
The viscosity of the solution was controlled by adding glycerin, which lowers the droplet Reynolds number and changes the wake dynamics of a droplet. The glycerin, however, does not affect the reaction nor the HPLC analysis. The glycerin concentration was fixed at either 10% or 30% (and 50%) for the set of experiments. Table III contains information about the experimental properties of the two phases as well as the droplets' parameters.

Results

Although the amount of iodine that phase transfers is not known ahead of time, the initial molar ratio of l-tyrosine to iodine can be determined a posteriori by using the measured concentration of reaction products. Although the absolute amounts cannot be known, the "molar charge ratio"—that is, the initial moles of l-tyrosine to the total moles of iodine that transferred phases—can be calculated as:











in which A o are the moles of l-tyrosine available for reaction; B o are the moles of iodine that transfer phases and are available for reaction; P is the concentration of 3-iodo-l-tyrosine in moles per liter, and BP stands for the byproduct concentration of 3,5-diiodo-l-tyrosine in moles per liter. A is the concentration of l-tyrosine at the end of the reaction in moles per liter. The selectivity Y P of the reaction was determined by dividing the total amount of desired product formed by the total amount of products formed:











The experiments focused on identifying how the selectivity varies with the initial molar charge ratio for experiments run with 10% and 30% glycerin.


ADVERTISEMENT

RELATED CONTENT
Roche Recalls Viracept
Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
Near-Infrared Assay and Content Uniformity of Tablets
Maintain Your Moving Parts
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here